scholarly journals Effects of Ganoderma Lucidum Extract on Morphine-Induced Addiction and Memory Impairment in Mice

2021 ◽  
Vol 12 (1) ◽  
pp. 1076-1084
Keyword(s):  
Conditioned Place Preference ◽  
Drug Addiction ◽  
Ganoderma Lucidum ◽  
Visual Memory ◽  
Memory Impairment ◽  
Short Term Memory ◽  
Memory Loss ◽  
Place Preference ◽  
Term Memory ◽  
Morphine Addiction

Ganoderma lucidum extract (Lingzhi) has been used so far with various pharmacological effects. However, the reports on its effects on drug addiction, especially morphine, and morphine-induced memory impairment in vivo, remain limited. In the present study, the effect of G. lucidum extracts on preventing morphine addiction was evaluated by the conditioned place preference model. The extract's learning and memory improvement activities on morphine-induced memory loss were examined using Y maze, novel recognition, and Morris water maze tests. The results found that G. lucidum extracts at doses of 200-400 mg/kg decreased conditioned place preference score and increased the percentage of alteration, novel object exploration, and prolongation of locating hidden platform. With these doses, G. lucidum extracts prevented morphine addiction and improved short-term memory, visual memory, and long-term memory impairment caused by morphine. Our results first demonstrated that G. lucidum extracts promised as an effective natural source in treating drug addiction and morphine-induced memory loss.

Short-Term Memory Loss Associated with Rosuvastatin

2006 ◽  
Vol 26 (8) ◽  
pp. 1190-1192 ◽  
Author(s):  
Laura Galatti ◽  
Giovanni Polimeni ◽  
Francesco Salvo ◽  
Marcello Romani ◽  
Aurelio Sessa ◽  
...  
Keyword(s):  
Short Term Memory ◽  
Memory Loss ◽  
Short Term ◽  
Term Memory

scholarly journals Phonological Short-Term Memory Impairment in Children with Down Syndrome

2021 ◽  
Vol 89 (6) ◽  
pp. 897-902
Author(s):  
EMAN F. EL-WAKIL, M.D.; RASHA M. SHOEIB, M.D. ◽  
YOSSRA A.N. SALLAM, M.D.; MAHA H. BOSHNAQ, M.D.
Keyword(s):  
Down Syndrome ◽  
Memory Impairment ◽  
Short Term Memory ◽  
Short Term ◽  
Term Memory ◽  
Children With Down Syndrome

scholarly journals High methionine, low folate and low vitamin B6/B12 (HM-LF-LV) diet causes neurodegeneration and subsequent short-term memory loss

2018 ◽  
Vol 33 (6) ◽  
pp. 1923-1934 ◽  
Author(s):  
Mohammed Nuru ◽  
Nino Muradashvili ◽  
Anuradha Kalani ◽  
David Lominadze ◽  
Neetu Tyagi
Keyword(s):  
Vitamin B6 ◽  
Short Term Memory ◽  
Memory Loss ◽  
Short Term ◽  
Term Memory

scholarly journals Short‐term memory impairment in vestibular patients can arise independently of psychiatric impairment, fatigue, and sleeplessness

2018 ◽  
Vol 13 (3) ◽  
pp. 417-431 ◽  
Author(s):  
Laura Smith ◽  
David Wilkinson ◽  
Mayur Bodani ◽  
Rowena Bicknell ◽  
S. S. Surenthiran
Keyword(s):  
Memory Impairment ◽  
Short Term Memory ◽  
Short Term ◽  
Term Memory

Clinical diagnosis of LGI1 antibody encephalitis in an 83-year-old woman

2021 ◽  
Vol 14 (1) ◽  
pp. e237398
Author(s):  
Jonathan E Attwood ◽  
Saniya Naseer ◽  
Sophia Michael ◽  
Josie Riley
Keyword(s):  
Cognitive Impairment ◽  
Clinical Diagnosis ◽  
Memory Impairment ◽  
Short Term Memory ◽  
Autoimmune Encephalitis ◽  
Short Term ◽  
Term Memory ◽  
Blood Tests ◽  
Abnormal Movements ◽  
History Of

An 83-year-old woman was referred to hospital with a 2-week history of short-lived episodic unpleasant sensations in her head and running down her body. This was accompanied by new short-term memory impairment and arm spasms. Initial investigations including blood tests and brain imaging did not reveal the diagnosis. The patient developed an increasing frequency of abnormal movements of her face and arm. These were clinically recognised as faciobrachial dystonic seizures (FBDS). FBDS are pathognomonic of an autoimmune encephalitis caused by an antibody directed against leucine-rich glioma-inactivated 1 (LGI1). The clinical diagnosis resulted in treatment with immunotherapy, leading to cessation of seizures and rapid cognitive recovery. Later, the predicted serology was confirmed. This reversible and under-recognised cause of cognitive impairment, typically affecting elderly patients, can be diagnosed clinically to enable early and effective treatment.

Sign in / Sign up

Export Citation Format

Share Document